Delving into the Latest Updates on IntegoGen, LLC with Synapse

概览

关联

1

项与 IntegoGen, LLC 相关的临床试验

NCT04541550

/ Withdrawn临床1期

An Open-label, Dose-escalation Study to Evaluate the Use of Allogeneic Micronized Amniotic Membrane Product for the Treatment of Hidradenitis Suppurativa

This study is an open-label, dose-escalation study enrolling 15 participants.
There are 3 cohorts:
1. Cohort I: 5 subjects each receiving 1 injection of IGN-AMP001 (12.5mg AMP-001 in 3ml Saline)
2. Cohort II: 5 subjects each receiving 1 injection of IGN-AMP001 (25 mg AMP-001 in 3 ml Saline)
3. Cohort III: 5 subjects each receiving 1 injection of IGN-AMP001 (50 mg AMP-001 in 3 ml Saline).

开始日期2021-04-01

申办/合作机构

IntegoGen, LLC

100 项与 IntegoGen, LLC 相关的临床结果

登录后查看更多信息

0 项与 IntegoGen, LLC 相关的专利（医药）

登录后查看更多信息

100 项与 IntegoGen, LLC 相关的药物交易

登录后查看更多信息

100 项与 IntegoGen, LLC 相关的转化医学

登录后查看更多信息